Project Grant HT94252510631
Award Date
9/1/25
Completion Date
8/31/29
Dollars Obligated
$2.5M
Federal Agency
Defense Health Agency
Awardee
Mayo Clinic (Y2K4F9RPRRG7)
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Rochester, MN 55905, USA
Similar Awards
The Defense Health Agency awarded a $1,162,900 Project Grant to the Mayo Clinic in Rochester, MN under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on July 15, 2025, is for the project "LAUNCHING THE ERA OF MELANOMA SURVIVORSHIP: DEFINING TREATMENT TARGETS IN QUALITY OF LIFE AND MENTAL HEALTH" and runs through July 14, 2028. The grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans,...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $2,124,536.00 to the Mayo Clinic in Rochester, Minnesota to conduct a clinical evaluation of combination immunotherapy for renal cell carcinoma (RCC). The award period runs from August 15, 2024 to August 14, 2027. The project aims to advance research into innovative treatment approaches for this form of kidney cancer, with the goal of improving outcomes for...
The Defense Health Agency has awarded a $968,400 Project Grant to Mayo Clinic to develop a personalized approach to treating drug-resistant ovarian cancer. The grant, which began on June 1, 2024, and will run through May 31, 2028, is funded under the Military Medical Research and Development program (CFDA 12.420). This program supports biomedical research to improve the health and care of military service members, veterans, and their families. Through this award, Mayo Clinic will leverage its...
The Defense Health Agency awarded a $597,543.00 Project Grant to Mayo Clinic Arizona, doing business as Mayo Clinic Hospital, a nonprofit academic medical center. The grant, which runs from October 1, 2023 to September 14, 2026, is funded under the Military Medical Research and Development program (CFDA 12.420) to support research aimed at "elucidating mechanisms of CAR-T cell immunotherapy resistance and sensitivity to improve treatment of myeloma." As a nonprofit organization with...
The federal Project Grant award of $161,400.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) will support Mayo Clinic's research project titled "AN ATLAS OF THE TUMOR IMMUNE CIRCULOME." This award, with a performance period from June 1, 2024 to May 31, 2025, aims to advance medical knowledge and improve patient care through innovative biomedical research. The Military Medical Research and Development program funds a wide range of...
The Department of the Army Medical Command awarded a $238,497 project grant to the Mayo Clinic in Rochester, Minnesota. The grant supports research from August 1, 2021 to July 31, 2025 under the Military Medical Research and Development program. The project aims to develop techniques for cytokine modulation of chimeric antigen receptor T cells to increase their safety and efficacy. This work supports the Military Medical Research and Development program's goals of transforming military and...
Mayo Clinic will receive $795,000 from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) to conduct the project "PHARMACODYNAMIC BIOMARKER-GUIDED METABOLIC COLLAPSE OF IDH-MUTANT GLIOMA" from September 2021 through September 2024. This Project Grant aims to develop medical solutions for the battlefield by investigating pharmacodynamic biomarkers to guide targeted metabolic therapies for the treatment of isocitrate...
The U.S. Defense Health Agency awarded Yale University a $912,487 Project Grant under the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to conduct research on the role of Polycomb Repressive Complex 1 in the progression of uveal melanoma. The 3-year research project, starting on September 15, 2023 and ending on September 14, 2026, aims to advance the understanding of this specific protein complex's involvement in the development and spread of a rare form...
The Mayo Clinic received a $278,250 project grant award from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund research from August 2021 through July 2025 to develop techniques for cytokine modulation of chimeric antigen receptor T cells to increase their safety and efficacy. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical research solutions...
This federal Project Grant award of $1,782,155.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research conducted by the Mayo Clinic to identify novel drug targets for lethal prostate cancer using liquid biopsy techniques. The award period runs from April 1, 2025 to March 31, 2028. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative biomedical investigations...